Skip to content
OddBrief
AI2 minPrimary source linked

UK accepts all 44 health AI recommendations, but 42 wait until spring 2027 for details

Britain's response to the NHS doctor-led AI commission accepts everything. Almost every line ends with the same promise of details next spring.

AI-assisted, human-reviewed

Illustration of a hospital monitor next to a stack of documents and a calendarAI
AI-generated illustration

Key facts

What
UK government response to the National Commission into the Regulation of AI in Healthcare
Accepted
all 44 recommendations; 42 say details will come by Spring 2027
First deadline
MHRA draft guidance on change control plans for adaptive AI devices by December 2026
Sandbox
AI Airlock Phase 3 open, first cohort chosen in November 2026

The UK government said on October 6 that it accepts all 44 recommendations of the National Commission into the Regulation of AI in Healthcare, the NHS doctor-led panel that reported in September. Read line by line, the response is mostly a schedule: 42 of the 44 entries end with a note that further details will be shared by Spring 2027.

The government frames it as a shift from one-time approval of AI medical devices to monitoring them for as long as they are in use. On the same day, the MHRA began taking applications for round three of AI Airlock, the sandbox where it tests AI devices with their makers.

What actually has a date

Only a few commitments come with a near-term deadline. The MHRA intends to publish draft guidance by December 2026 on predetermined change control plans, which would let makers set boundaries in advance for how an adaptive AI device may change without a fresh approval. Consultation on how AI products qualify and are classified as medical devices, the commission's first recommendation, is due by Spring 2027.

A full implementation roadmap, with roles and timelines for all 44 recommendations, is also promised by Spring 2027, followed by annual progress updates. Many of the bigger changes, such as staged authorisation that would allow hospitals to try promising tools sooner while regulators watch them closely, depend on possible licensing powers or secondary legislation that the response says the MHRA will "explore" or "consider".

The sandbox moves to after-launch monitoring

AI Airlock's third phase focuses on post-market surveillance: how to watch an AI device's performance after it is deployed. It has three more years of government funding. A webinar for applicants is set for October 22, and the first wave of companies will be chosen in November 2026.

Commission chair Alastair Denniston said the response listened to "more than 12,000 patients, clinicians and members of the public" who fed into the recommendations.

Patients and redress

One recommendation covers what happens when AI-assisted care goes wrong. DHSC will convene a working group, including the Patient Safety Commissioner, to make sure patients have access to redress when care falls below what is reasonably expected. Like most of the response, its details are due next spring.

Scotland said it will set out its own response in due course. The test of today's "accept in full" will be how much of the Spring 2027 roadmap comes with firm dates.

Sources